ÂÜÀòÂÒÂ×

Osagie Imasogie is a prominent figure in the pharmaceutical and therapeutic sectors, currently serving as an Inaugural Member of the President’s Advisory Council on African Diaspora at the United States Government - White House - State Department since September 2023. Imasogie holds the position of Chairman of the Board at Zelira Therapeutics since September 2019 and has been the Senior Managing Partner at PIPV Capital since 2004. Imasogie co-founded several companies including Churchill Pharmaceuticals LLC, iCeutica, and Trigensis Therapeutics, and held various leadership roles in firms such as Iroko Pharmaceuticals and Ception Therapeutics. With a strong educational background in law from institutions including the University of Pennsylvania and The London School of Economics, Imasogie’s expertise spans intellectual property and international economic law.